Skip to main content

Advertisement

SpringerLink
Log in

Antineoplastic activity of artemisinin in adrenocortical carcinoma

  • Research Letter
  • Published:
Endocrine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Y. Zhang, G. Xu, S. Zhang, D. Wang, P. Saravana Prabha, Z. Zuo, Antitumor research on artemisinin and its bioactive derivatives. Nat. Prod. Bioprospect. 8(4), 303–319 (2018)

    Article  Google Scholar 

  2. Z. Li, Q. Li, J. Wu, M. Wang, J. Yu, Artemisinin and its derivatives as a repurposing anticancer agent: what else do we need to do? Molecules 21(10), 1331 (2016)

    Article  Google Scholar 

  3. T. Efferth, E. Koch, Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr. Drug Target 12(1), 122–132 (2011)

    Article  CAS  Google Scholar 

  4. L.A. Panossian, N.I. Garga, D. Pelletier, Toxic brainstem encephalopathy after artemisinin treatment for breast cancer. Ann. Neurol. 58(5), 812–813 (2005)

    Article  Google Scholar 

  5. L. Liu, L.F. Zuo, J.W. Guo, Reversal of multidrug resistance by the anti-malaria drug artesunate in the esophageal cancer Eca109/ABCG2 cell line. Oncol. Lett. 6(5), 1475–1481 (2013)

    Article  CAS  Google Scholar 

  6. J.-L. Zhang, Z. Wang, W. Hu, S.-S. Chen, X.-E. Lou, H.-J. Zhou, DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma. Microvasc. Res. 87, 14–24 (2013)

    Article  CAS  Google Scholar 

  7. S.-J. Wang, Y. Gao, H. Chen, R. Kong, H.-C. Jiang, S.-H. Pan et al. Dihydroartemisinin inactivates NF-κB and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo. Cancer Lett. 293(1), 99–108 (2010)

    Article  CAS  Google Scholar 

  8. T. Efferth, Cancer combination therapies with artemisinin-type drugs. Biochemical Pharmacol. 139, 56–70 (2017)

    Article  CAS  Google Scholar 

  9. R. Libé, I. Borget, C.L. Ronchi, B. Zaggia, M. Kroiss, T. Kerkhofs et al. Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study. Ann. Oncol. 26(10), 2119–2125 (2015)

    Article  Google Scholar 

  10. A. Berruti, R. Libè, M. Laganà, H. Ettaieb, M.A. Sukkari, J. Bertherat et al. Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. Eur. J. Endocrinol. 180(5), 311–320 (2019)

    Article  CAS  Google Scholar 

  11. M. Fassnacht, O.M. Dekkers, T. Else, E. Baudin, A. Berruti, R.R. de Krijger et al. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 179(4), G1–G46 (2018)

    Article  CAS  Google Scholar 

  12. L. Ferrari, M. Claps, S. Grisanti, A. Berruti, Systemic therapy in locally advanced or metastatic adrenal cancers: a critical appraisal and clinical trial update. Eur. Urol. Focus. 1(3), 298–300 (2016)

    Article  Google Scholar 

  13. P. Sperone, A. Ferrero, F. Daffara, A. Priola, B. Zaggia, M. Volante et al. Gemcitabine plus metronomic 5-fluorouracil or capecitabine as a second-/third-line chemotherapy in advanced adrenocortical carcinoma: a multicenter phase II study. Endocr. Relat. Cancer 17(2), 445–453 (2010)

    Article  CAS  Google Scholar 

  14. J.E.K. Henning, T. Deutschbein, B. Altieri, S. Steinhauer, S. Kircher, S. Sbiera et al. Gemcitabine-based chemotherapy in adrenocortical carcinoma: a multicenter study of efficacy and predictive factors. J. Clin. Endocrinol. Metab. 102(11), 4323–4332 (2017)

    Article  Google Scholar 

  15. M. Terzolo, F. Daffara, A. Ardito, B. Zaggia, V. Basile, L. Ferrari et al. Management of adrenal cancer: a 2013 update. J. Endocrinol. Investig. 37(3), 207–217 (2014)

    Article  CAS  Google Scholar 

  16. D. Cosentini, S. Grisanti, V.A. Dalla, M. Laganà, C. Fiorentini, P. Perotti et al. Immunotherapy failure in adrenocortical cancer: where next? Endocr. Connect. 7(12), E5–E8 (2018)

  17. G. Assié, E. Letouzé, M. Fassnacht, A. Jouinot, W. Luscap, O. Barreau et al. Integrated genomic characterization of adrenocortical carcinoma. Nat. Genet. 46(6), 607–612 (2014)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy

    Luigi Lorini, Salvatore Grisanti, Deborah Cosentini, Marta Laganà & Alfredo Berruti

  2. Radiology Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili, Brescia, Italy

    Roberta Ambrosini & Luigi Grazioli

  3. Surgical Unit, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia. ASST Spedali Civili di Brescia, Brescia, Italy

    Guido A. M. Tiberio

  4. Section of Pharmacology, Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy

    Sandra Sigala

Authors
  1. Luigi Lorini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Salvatore Grisanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberta Ambrosini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Deborah Cosentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marta Laganà
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luigi Grazioli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guido A. M. Tiberio
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sandra Sigala
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alfredo Berruti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alfredo Berruti.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was supported with the contribution of FIRM Foundation (Cremona, Italy).

Informed consent

Informed consent was obtained from the patient included in the study.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lorini, L., Grisanti, S., Ambrosini, R. et al. Antineoplastic activity of artemisinin in adrenocortical carcinoma. Endocrine 66, 425–427 (2019). https://doi.org/10.1007/s12020-019-02077-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-019-02077-7

Search

Navigation